MedPath

Prorhythm, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

High Intensity Focused Ultrasound (HIFU) Ablation System Study

Phase 3
Suspended
Conditions
Atrial Fibrillation
Interventions
Device: Pulmonary vein ablation
Drug: sotolol
First Posted Date
2006-10-25
Last Posted Date
2008-06-17
Lead Sponsor
ProRhythm, Inc.
Target Recruit Count
240
Registration Number
NCT00392106
Locations
🇺🇸

Fullerton Vascular Medical Group, Fullerton, California, United States

🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

🇺🇸

Piedmont Hospital, Atlanta, Georgia, United States

and more 18 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.